首页> 外国专利> CORONAVIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T CELLS COMPRISING THE SAME AND USES THEREOF

CORONAVIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T CELLS COMPRISING THE SAME AND USES THEREOF

机译:冠状病毒特异性T细胞受体融合构建体,编码该融合构建体的载体,包含该融合构建体的T细胞及其用途

摘要

The present invention is inter alia concerned with a T cell receptor fusion construct comprising two specific peptidic moieties, one of these two moieties binding to the spike protein from coro- naviruses and binding to ACE2, in particular the spike proteins from SARS-CoV-2 and/or SARS- CoV-1, and one of these moieties being a protein of the T cell receptor complex. A vector comprising the genetic information encoding the T cell receptor fusion construct is also part of the present invention, as well as a process of transfecting or transducing T cells and a modified T cell comprising the T cell receptor fusion construct. Importantly, the present invention also relates to a T cell receptor fusion construct, a vector or a modified T cell for use in the treatment of a disease and in particular for use in the treatment of a disease caused by a coronavirus such as e.g. COVID-19 or SARS.
机译:本发明尤其涉及包含两个特定肽部分的T细胞受体融合构建体,这两个部分中的一个与冠状病毒的棘突蛋白结合并与ACE2结合,特别是来自SARS-CoV-2和/或SARS-CoV-1的棘突蛋白,其中一个部分是T细胞受体复合物的蛋白。包含编码T细胞受体融合构建体的遗传信息的载体也是本发明的一部分,以及转染或转导T细胞和包含T细胞受体融合构建体的修饰T细胞的过程。重要的是,本发明还涉及用于治疗疾病,尤其是用于治疗由冠状病毒(例如2019冠状病毒疾病或SARS)引起的疾病的T细胞受体融合构建体、载体或修饰的T细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号